Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

The medical center is at the forefront of research in respiratory infections and pulmonary diseases, focusing on innovative treatments and preventive measures. The center's work in this area is crucial for developing new therapies that improve patient outcomes and quality of life.

• Recurrent Lower Respiratory Tract Infections (RLRTIs)
• Pulmonary Sarcoidosis
• Idiopathic Pulmonary Fibrosis (IPF)

Through rigorous clinical trials, the center is advancing the understanding of these conditions and exploring novel therapeutic approaches.

Specializing in oncology and hematology, the center is dedicated to pioneering research in cancer treatment, particularly in challenging cases of relapse and refractory conditions. The institution's commitment to innovation is evident in its diverse clinical trials aimed at improving survival rates and patient care.

• Non-Small Cell Lung Cancer (NSCLC)
• Head and Neck Squamous Cell Carcinoma (HNSCC)
• Multiple Myeloma

The center's research is instrumental in developing targeted therapies and personalized medicine strategies.

With a strong focus on autoimmune and inflammatory diseases, the center is leading efforts to understand and treat complex conditions that affect millions worldwide. The research conducted here is vital for discovering new treatment modalities that can significantly alter disease progression.

• Systemic Lupus Erythematosus (SLE)
• Dermatomyositis
• Hidradenitis Suppurativa (HS)

By exploring the underlying mechanisms of these diseases, the center aims to develop more effective and safer therapeutic options.

The center is a leader in neurology and neurodegenerative disorders, focusing on innovative research to combat these debilitating conditions. The institution's work is crucial for advancing the understanding and treatment of neurological diseases.

• Multiple Sclerosis (MS)
• Multiple System Atrophy (MSA)

Through cutting-edge research, the center is paving the way for new therapies that can improve patient outcomes and quality of life.

Focusing on cardiovascular and metabolic disorders, the center is dedicated to advancing research in these critical areas. The institution's efforts are aimed at developing new treatments that can effectively manage and prevent these widespread health issues.

• Acute Coronary Syndrome
• Sickle Cell Disease (SCD)

The center's research is essential for understanding the complex interactions between these disorders and developing comprehensive treatment strategies.